CN1647805A - Health food having delaying senility and beautifying function and its preparing method - Google Patents
Health food having delaying senility and beautifying function and its preparing method Download PDFInfo
- Publication number
- CN1647805A CN1647805A CN 200410002629 CN200410002629A CN1647805A CN 1647805 A CN1647805 A CN 1647805A CN 200410002629 CN200410002629 CN 200410002629 CN 200410002629 A CN200410002629 A CN 200410002629A CN 1647805 A CN1647805 A CN 1647805A
- Authority
- CN
- China
- Prior art keywords
- extract
- radix
- health food
- parts
- slow down
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims description 15
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims abstract description 47
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 47
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 47
- 244000068988 Glycine max Species 0.000 claims abstract description 37
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 37
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 26
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 13
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 13
- 229940046009 vitamin E Drugs 0.000 claims abstract description 13
- 239000011709 vitamin E Substances 0.000 claims abstract description 13
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 59
- 239000000706 filtrate Substances 0.000 claims description 35
- 230000032683 aging Effects 0.000 claims description 34
- 239000000843 powder Substances 0.000 claims description 34
- 239000008187 granular material Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 25
- 238000010438 heat treatment Methods 0.000 claims description 23
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 22
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 14
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 14
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 14
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 14
- 229920000881 Modified starch Polymers 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 13
- -1 hydroxypropyl Chemical group 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 13
- 239000000741 silica gel Substances 0.000 claims description 12
- 229910002027 silica gel Inorganic materials 0.000 claims description 12
- 235000019154 vitamin C Nutrition 0.000 claims description 12
- 239000011718 vitamin C Substances 0.000 claims description 12
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 11
- 229930003268 Vitamin C Natural products 0.000 claims description 11
- 239000000047 product Substances 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 10
- 239000000341 volatile oil Substances 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- 229960004793 sucrose Drugs 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 239000002932 luster Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 238000007493 shaping process Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000010410 dusting Methods 0.000 claims description 5
- 239000004503 fine granule Substances 0.000 claims description 5
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 238000007689 inspection Methods 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 238000005453 pelletization Methods 0.000 abstract 1
- 238000001694 spray drying Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 206010008570 Chloasma Diseases 0.000 description 23
- 208000003351 Melanosis Diseases 0.000 description 23
- 239000000523 sample Substances 0.000 description 18
- 235000013399 edible fruits Nutrition 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 11
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 9
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 229940011871 estrogen Drugs 0.000 description 7
- 239000000262 estrogen Substances 0.000 description 7
- 241000532370 Atla Species 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 239000006199 nebulizer Substances 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000003796 beauty Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000008539 xiaoyao Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000288673 Chiroptera Species 0.000 description 2
- 241000255601 Drosophila melanogaster Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000748 compression moulding Methods 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 240000007509 Phytolacca dioica Species 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The health food with functions of delaying senility and beautifying is prepared with soybean isoflavone, bupleurum root, angelica, white peony root, mint, white atractylodes rhizome, ginger, tuckahoe, licorice, vet C, vitamin E and excipient. It is prepared through compounding in certain proportion, separate extraction, spray drying, adding excipient, pelletizing in fluidized bed and tabletting.
Description
Technical field
The present invention relates to a kind of health food and preparation method thereof, belong to field of health care food with slow down aging and beautification function.
Background technology
Be the aging of delaying female physiological, developed country just brings into use Hormone Replacement Therapy from the fifties, and low dosage is taken the estrogens medicine over a long time, to keep the body inner estrogen in safe and rational level.But long-time clinical use is observed and is found that there is certain side effect in this therapy, and the people as nearly 1% can vaginal hemorrhage occur or vaginal secretions increases, distending pain of the breast, gastrointestinal reaction etc.; Next has potential carcinogenic danger and has more contraindication.Therefore, the natural extract of searching estrogen-like effects becomes one of focus of international research in recent years.
The soybean isoflavone that extracts from Semen sojae atricolor is present universally acknowledged " natural plants estrogen " safely and effectively, is that the product of active ingredient becomes the important dietary supplement of developed country's middle and aged women with the soybean isoflavone.Chinese patent CN1449763A discloses the invention of " soybean isoflavone aglycones composition and method of making the same and purposes ", and the total content of three kinds of isoflavone reaches 90-100% in the said composition, is used for the treatment of climacteric syndrome and person in middle and old age's occlusive cardiovascular and cerebrovascular disease.CN1401320A discloses a kind of by soybean isoflavone or daidzein 1-3 weight portion, the medicine of the treated climacteric syndrome that wolfberry fruit extract 1-3 weight portion is made.CN1416728A discloses with Semen sojae atricolor, Herba Epimedii, the Radix Astragali, Radix Angelicae Sinensis and Fructus Mori are effective ingredient, join again with the adjuvant calcium gluconate, carboxymethyl starch sodium and microcrystalline Cellulose are formed, and have the health food of bone density improving and delaying senility function.
On the other hand, cause that by decrease in estrogen the influence that the female pathology aging is produced is many-sided, the replacement therapy of single estrogen or natural estrogen sample material, though to a certain degree can relief of symptoms, but to endocrine dysfunction that has delayed or formed and the various degeneration variations that bring, the various clinical symptoms relevant with feelings will of lacking of proper care, effect is not satisfactory.
The XIAOYAO POWDER that is widely used in gynecological clinic, record the earliest in " formulary of peaceful benevolent dispensary ", by Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae, Rhizoma Zingiberis Recens is formed, this side's composition overwhelming majority is for medicine-food two-purpose or listed healthy food material list Chinese medicine composition in, with and not high, embellish but not dry, has dispersing the stagnated live-QI to relieve the stagnation of QI, the spleen invigorating of nourishing blood, the function of mediation whole body QI and blood, can obviously improve the mental status of human body, pharmacological research proves that this can endocrine regulation, regulate the central nervous system, health invigorating, effects such as hepatoprotective, clinical various gynecological diseases and the degenerative diseases of aged of being used for the treatment of.But onset is slow, need take the long period can take effect.
Summary of the invention
The object of the present invention is to provide a kind of health food with slow down aging and beautification function.
Another object of the present invention has provided the preparation method of this health food.
Technical scheme of the present invention is:
A kind of health food with slow down aging and beautification function, it mainly is to be made by the raw material of following weight portion: soybean isoflavone 1-6 part, Radix Bupleuri 2-6 part, Radix Angelicae Sinensis 2-6 part, Radix Paeoniae Alba 2-6 part, Herba Menthae 0.4-1.2 part, Rhizoma Atractylodis Macrocephalae 2-6 part, Rhizoma Zingiberis Recens 2-6 part, Poria 2-6 part, Radix Glycyrrhizae 1.6-4.8 part, vitamin C 0.6-4 part, vitamin E 0.3-2 part, excipient 0.1-40 part.
Optimized technical scheme has following:
Health food with slow down aging and beautification function, its excipient 7.8-40 part.
Health food with slow down aging and beautification function, its excipient is made up of following materials of weight proportions single or multiple combination: pregelatinized Starch 2.5-10 part, low-substituted hydroxypropyl cellulose 2.5-10 part, microcrystalline Cellulose 2.5-15 part, micropowder silica gel 0.1-2.5 part, hydroxypropyl emthylcellulose 0.2-5 part, cane sugar powder 0-20 part, mannitol 0-10 part.
Health food with slow down aging and beautification function, the total isoflavone content of soybean isoflavone is 10-90%.
Health food with slow down aging and beautification function, the total isoflavone content of soybean isoflavone is 30-50%.
Health food with slow down aging and beautification function, form are tablet, capsule, granule and powder.
Another object of the present invention is the preparation method that discloses the health food with slow down aging and beautification function, and the health food preparation of its tablet form is operated by following step:
(1) extract of prefabricated Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, Rhizoma Zingiberis Recens: get Radix Bupleuri by weight ratio, Radix Angelicae Sinensis, Herba Menthae, the Rhizoma Atractylodis Macrocephalae, Rhizoma Zingiberis Recens, add in the decoction pot, add 30-60 part water, soaked overnight, behind the heating extraction volatile oil C, decocting liquid filters, and medicinal residues add water 40-50 part again, heated and boiled 1 hour, the filtrate extract merges filtrate twice, leaves standstill cooling, filter, filtrate heating is condensed into the extractum that proportion is 1.0-1.3, and drying is the prefabricated extract A of Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, Rhizoma Zingiberis Recens;
(2) extract of the prefabricated Radix Paeoniae Alba, Poria, Radix Glycyrrhizae: get the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae by weight ratio, add in the Decocting pot, add the water of 15-30 part, soaked overnight, heating decocted 2 hours, the filtrate extract, medicinal residues add water 20-25 part again, heated and boiled 1 hour, filtrate extract, merge filtrate twice, leave standstill cooling, filter, the filtrate heating is condensed into the extractum that proportion is 1.0-1.3, drying promptly gets the prefabricated extract B of the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae;
(3) with the soybean isoflavone powder behind the crushing screening, prefabricated extract A, prefabricated extract B, vitamin E, microcrystalline Cellulose, low-substituted hydroxypropyl cellulose, pregelatinized Starch and vitamin C, divide another name fixed, put be mixed to the color and luster uniformity in the V-type blender after, put pelletize in the fluidized bed pelletizer, its control process parameters is as follows: air intake 30-50 ℃, vibrate atomizing pressure 0.10-0.2bar, hydrojet speed 50-70g/ minute 2-6 time/minute, air door pressure 0.05-0.2mpa, auxiliary pneumatics 0.10-0.2mpa when treating that shaping particles is better, enters dry for the first time, inlet temperature is elevated to 60-90 ℃, vibrate air door pressure 0.1-0.3mpa, aux. pressure 0.10-0.2mpa 2-6 time/minute, when the granule water content is controlled at 0.5-3.5%, take out granule;
(4) granule that makes sifts out the parts of fine granule by 16 mesh sieve granulate with 60 order dusting covers, adds the volatile oil C that extract (1), mixing the back thoroughly adds in the material, add micropowder silica gel again, abundant airtight spending the night behind the mixing, put 21 in the rotary tablet machine tabletting, sift out fine powder, remove useless sheets such as loose sheet, sliver, stain, sampling inspection changes in the coating pan after qualified, with hydroxypropyl emthylcellulose coating materials coating, obtain finished product.
By the health food that prescription of the present invention is made, have the effect and the functions of removing chloasma of slow down aging and improve the beautification function of skin moisture, and health is had no adverse effects.
The invention has the advantages that: with soybean isoflavone and Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae, Rhizoma Zingiberis Recens reasonable compatibility, natural estrogen sample effect by soybean isoflavone, be equipped with XIAOYAO POWDER prescription endocrine regulation system and central nervous system functions such as Radix Bupleuri, Radix Angelicae Sinensis, simultaneously an amount of forced for vitamins C and vitamin E, reach treating both the principal and secondary aspects of a disease, can prevent the decline of women's ovarian function, postpone climacteric or improve menopause syndrome, prevention or postponement skin aging, prevention of osteoporosis and cardiovascular disease.
Soybean isoflavone raw material powder and XIAOYAO POWDER extract all have stronger hygroscopicity, and easily bonding is agglomerating after the moisture absorption, and phenomenons such as loose sheet, sliver, sticking appear in the very difficulty of operation of granulating easily in the tabletting process, and the disintegration of tablet time of extrusion surpasses the pharmacopeia regulation.The preparation technology that additional benefit of the present invention provides has successfully solved the problems referred to above, not only granulate, the tabletting process is smooth, and the hardness that is pressed into tablet can reach more than 4 kilograms, and the disintegration time of plain sheet is in 10 minutes.
By the further capable beneficial effect of setting forth health food of the present invention of following test.
Health food deferring senility experimental result of the present invention:
Sample source and processing: the health food tablet that anthology inventive embodiments 2 provides, the 0.6g/ sheet, it is 2.4g/ people/sky that human body is recommended daily intaking amount.Sample directly is mixed with the suspension of desired concn with distilled water, is provided with down test and uses.
1, drosophila survival experiment:
1.1 laboratory animal: OregonK wild type Drosophila melanogaster (Drosophila melanogaster) 1.2 method for breeding: adopt flat cultivation vial to cultivate, 20 of every pipes, in the constant temperature culture chamber that to put 25 ± 1 ℃ of relative humiditys be 45-75%, changed a subculture in per four days.Basal medium prescription following (is example with the 100ml cultivation):
Table 1
Component Semen Maydis powder sucrose agar propanoic acid yeast powder water
(g) (g) (g) (ml) (g) (ml)
Consumption 85 65 7.5 5 7.5 1000
1.3 dosage: establish 1 blank group and 0.027%, 0.08%, 0.24%, 0.72% 4 dosage group.
1.4 experimental technique: collect in eight hours the new fruit bat adult that sprouts wings, etherization is distinguished the male and female random packet down, is experimentized after weighing respectively.Use 400 of fruit bats, male and female half and half for every group.Matched group gives conventional corn powder culture medium: conventional raise the culture medium that test group after 25 days contains sample 0.027%, 0.08%, 0.24%, 0.72% respectively.Every day observed and recorded drosophila survival number and death toll, till the whole death of fruit bat.Calculate three indexs such as the dead natural law of half, average life and average maximum life span.
1.5 result: see Table 1 as seen, sample tablet 0.08%, 0.24%, 0.72% dosage group can obviously prolong the average life of hero, female fruit bat, with the matched group comparing difference significance P<0.01, P<0.01, P<0.05, P<0.01, P<0.01, P<0.01 is arranged; 0.027%, 0.08%, 0.24%, 0.72% dosage group can obviously prolong the maximum life span of male drosophila, than difference significance is arranged compared with the control, P<0.01, P<0.01, P<0.01, P<0.05; 0.08%, 0.24%, 0.72% dosage group can obviously prolong the maximum life span of female fruit bat, the difference of comparing with matched group has significance, P<0.05, P<0.01, P<0.01,0.08%, 0.24% dosage group male drosophila half death time respectively greater than matched group 6 days, 10 days, 0.08%, 0.24%, female fruit bat half death time of 0.72% dosage group respectively greater than matched group 7 days, 8 days, 8 days.
The influence that table 2 sample is tested drosophila survival (X ± SD)
The examination substrate concentration
Sample number (only) Average weight (ug) The half death time (my god) Average life (my god) Average maximum life span (my god)
(%) male male and female male and female male and female male and female are female
0.0 228 229 891 995 47 55 47.9±11.2 54.8±12.7 68.3±2.2 78.1±3.0
0.027 231 231 886 987 48 58 50.1±13.0 57.1±13.4 74.5±2.9** 78.9±2.4
0.08 225 232 880 996 53 62 53.9±12.8** 60.3±13.9** 78.5±3.2** 80.3±2.8*
0.24 226 229 896 990 57 63 59.5±13.0** 61.0±13.7** 83.0±1.0** 82.9±1.9**
0.72 227 231 890 1001 50 63 51.4±11.0* 62.5±15.2** 70.9±3.9* 86.3±3.2**
Compare * P<0.05 * * P<0.01 with matched group
The average maximum life span of a is calculated by 20 fruit bats of longest-lived.
2, biochemical indicator detects:
2,1 test animal: SPF level Kunming kind female 12 the monthly age 40 of mices, 10 of 1 monthly age male mices, the animal feeding room temperature is 22-24 ℃, humidity is 65-80%.
2,2 dosage grouping: press MDA level grouping in the blood before the test, aged mouse is divided into 1 aged control and basic, normal, high dosage group at random.Recommend 5,10,20 times of human body daily intaking amount (2.4g/560kg.BW) to be equivalent to manufacturer, as basic, normal, high dosage group (corresponding actual dose be 0.20,0.40,0.80g/kg.BW).Basic, normal, high dosage group is pressed 0.10ml/10g.BW capacity per os with the sample distilled water preparation liquid of variable concentrations respectively and is irritated stomach; Matched group is irritated stomach and is given with the volume distilled water.
2,3 experimental techniques: after animal was fed one month continuously, eyeball was got blood, prepared 2% hemolysate, made 2% hemolysate MDA content and whole blood GSH-PX and measured, and preparation erythrocyte extract is made the erythrocyte sod vitality test.
2,4 statistical method: adopt EXCELL software to carry out the T check.
2,5 results: see Table 3,4, the basic, normal, high dosage group of this product can obviously reduce aged mouse 2% hemolysate MDA content, with aged matched group comparing difference remarkable P<0.01, P<0.01, P<0.01 is arranged; The basic, normal, high dosage group aged mouse whole blood GSH-PX activity that can obviously raise has significance P<0.01, P<0.01, P<0.01 with aged matched group comparing difference; The basic, normal, high dosage group red SOD activity of aged mouse that can obviously raise has significance P<0.05, P<0.01, P<0.01 with aged matched group comparing difference.
The influence of table 3 pair aged mouse body weight (X ± S)
Group dosage number of animals
Initial weight is heavy eventually
(g/kg.BW) (only) g g
Aged contrast 0.00 10 55.3 ± 2.9 56.5 ± 4.0
Low dose group 0.20 10 53.2 ± 3.3 54.0 ± 2.6
Middle dosage group 0.40 10 53.4 ± 3.6 53.9 ± 1.9
High dose group 0.80 10 54.5 ± 3.4 55.3 ± 3.1
Table 4 sample is to the influence of MDA content in the aged mouse blood (X ± S)
Group dosage number of animals MDA (nmol/ml)
(g/kg.BW) (only)
After testing before the test
2% hemolysate, 2% hemolysate
Aged contrast 0.0 10 24.1 ± 2.3 24.9 ± 2.0
Low dose group 0.20 10 24.2 ± 2.3 20.9 ± 3.2**
Middle dosage group 0.40 10 24.9 ± 1.9 20.4 ± 1.6**
High dose group 0.80 10 24.7 ± 1.9 20.6 ± 2.6**
Contrast 0.0 10-18.3 ± 3.0** few age
Compare * * P<0.01 with aged matched group
Table 5 sample is to the influence of aged mouse erythrocyte, SOD, whole blood GSH-PX (X ± S)
Group dosage number of animals
SOD (U/gHb) GSH-PX (U/ml)
(g/kg.BW) (only) erythrocyte whole blood
Aged contrast 0.0 10 75334 ± 7,460 39.3 ± 6.3
Low dose group 0.20 10 85307 ± 11416*, 55.2 ± 12.2**
Middle dosage group 0.40 10 87881 ± 9398**, 57.4 ± 10.8**
High dose group 0.80 10 91051 ± 11852**, 58.2 ± 8.9**
Contrast 0.0 10 100415 ± 9313**, 58.5 ± 9.5** few age
Compare * P<0.05 * * P<0.01 with aged matched group
The result shows that as seen drosophila survival experiment and biochemical indicator detect, and with the matched group comparing difference significance are arranged, and according to health food function assessment assessment process regulation, this is tried thing delaying senility function.
Health food beauty treatment of the present invention (functions of removing chloasma) effect clinical observation:
Sample source and processing: the health food tablet that anthology inventive embodiments 2 provides, 0.6g/ sheet.
The report of beauty treatment (functions of removing chloasma) experimental check:
Sample source and processing: derive from the sample that embodiment 1 provides, sample is made 0.6 gram/sheet, is provided with down test and uses.
30 satisfactory chloasma experimenters take sample, and each 2, every day 2 times, continuous 30 days.The chloasma area 6.79 ± 8.19cm2 that on average descends as a result, color obviously shoals, and colour atla on average reduces by 0.30 ± 0.36 degree, in 30 examples, produce effects 3 examples, effective 16 examples, total effective rate 63.33%.Routine blood test, routine urinalysis and bloodization are given birth to index all in normal range before and after the test-meal, can think, sample has beauty treatment (functions of removing chloasma) effect, and the healthy nothing of examination trencherman is obviously influenced.
Object and method:
Tried thing: the sample that embodiment 1 method provides.
Study subject: press the principle of voluntariness and select 18-65 year, have chloasma experimenter 30 examples.
Diagnostic criteria: the visible brown spot of women's head-ornaments portion perusal is mainly in and cheekbone, cheek, volume, nose, lip week etc. locates symptoms such as no sufferings.
The person's of including in standard: all volunteers that chloasma is arranged, all can carry out test-meal through medical fitness and observe.
Eliminator's standard:
1 age, gestation or women breast-feeding their children were to these health product allergy sufferers under-18s or over-65s person.
Be associated with serious primary disease such as conscience kidney and hemopoietic system, the psychotic.
Do not meet the standard of including in,, can't judge effect or data not umbra sound effect or safety judgement person not in accordance with regulations with being tried thing.
Contrast form: adopt self cross-reference form.
Taking dose and time; Each 2, every day 2 times, continuous 30 days.The experimenter cuts out medicine or other health product and the cosmetics of relevant face-beautifying and spot-removing at experimental session.
Instrument and reagent: F-820 type blood counting instrument, ten analyses of MIDIRON urine (Germany produces), Olympus automatic clinical chemistry analyzer (Japan produces), model AU600, Institute of Geography, Academia Sinica's development and design, Mapping Press published " practical standard colour atla " (front page) in 1992, and the biochemical reagents box is all provided by middle living company.
Observation index:
Each is checked once before and after the experiment.
The effect observation:
Ordinary circumstance:
Detailed medical history-taking is understood experimenter's diet situation, observes main clinic symptoms: feeling of fatigue, agitation, sleep etc.Before and after test-meal, add up integrated value by symptom weight (serious symptom 3 minutes, moderate 2 minutes, light disease 1 minute), and improve (2 fens produce effects of each doing well,improving are improved 1 and are divided into effectively), calculate the improvement rate with regard to its cardinal symptom.
The head chloasma detects:
The area size changes: the major diameter and the wide footpath of same chloasma before and after being tried with tape measure, reference area (cm2).
Shade changes:
According to Institute of Geography, Academia Sinica's development and design, brown (Y+M+BK i.e. Huang+magenta+black folded color) colour atla in " practical standard colour atla " (front page) that Mapping Press published in 1992 is the criterion of chloasma shade: I degree (15,20,5), II degree (30,40,10), III degree (40,60,15).
Spot-removal function is judged:
Produce effects: chloasma color decline II degree, or area dwindle 〉=30%, do not produce new chloasma.
Effectively: chloasma color decline I degree, or 10%<area dwindle<30% do not produce new chloasma.
Invalid: the chloasma area dwindles<and 10%, color does not have significant change.
Therapeutic outcome (see Table 6, table 7, table 8, table 9 and table 10):
Table 6 chloasma shade after treating changes
Difference after the test-meal before the test-meal of example number
Colour atla (degree) 30 2.17 ± 0.46 1.87 ± 0.43-0.30 ± 0.36**
**P<0.01
Table 7 is chloasma area size variation after treating
Difference after the test-meal before the test-meal of example number
Chloasma area (cm
2) 30 58.22 ± 35.22 51.43 ± 32.84-6.79 ± 8.19**
**P<0.01
The evaluation of table 8 effect
Produce effects enabledisable total effective rate (%)
Example several 3 16 11 19
Effect rate (%) 10.00% 53.33% 36.67% 63.33%
Table 9 cardinal symptom is improved situation
Cardinal symptom example digital display is imitated enabledisable total effective rate (%)
Feeling of fatigue 26 2 13 11 57.69
Irritated 21 1 11 9 57.14
Sleep 20 1 10 9 55.00
Table 10 symptom integral changes
Before the example number test-meal in the test-meal after the test-meal
30 7.83±3.80 6.33±2.97 4.13±1.85**
**P<0.01
As a result, 30 routine chloasma experimenters took 30 days on request continuously, and the chloasma area on average dwindles 6.79 ± 8.19cm
2P<0.01, color shoals, and colour atla on average reduces by 0.30 ± 0.36 degree, P<0.05, produce effects 3 examples wherein, effective 16 examples, total effective rate 63.33% shows beauty treatment is arranged (functions of removing chloasma) effect, and symptoms such as chloasma experimenter's feeling of fatigue, agitation, sleep are had the improvement effect.
The specific embodiment
Embodiment 1
The preparation of tablet of the present invention:
1 part of soybean isoflavone, 2 parts of Radix Bupleuri, 2 parts of Radix Angelicae Sinensis, 0.4 part of Herba Menthae, 2 parts of the Rhizoma Atractylodis Macrocephalaes, 2 parts in Rhizoma Zingiberis Recens, 2 parts of the Radix Paeoniae Albas, 2 parts in Poria, 1.6 parts in Radix Glycyrrhizae, 0.6 part of vitamin C, 0.3 part of vitamin E, 10 parts of pregelatinized Starch, 10 parts of low-substituted hydroxypropyl celluloses, 2.5 parts of microcrystalline Cellulose, 0.1 part of micropowder silica gel, 0.2 part of hydroxypropyl emthylcellulose.
Preparation method: (1). prefabricated Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, the extract of Rhizoma Zingiberis Recens: by the Radix Bupleuri of described weight proportion, Radix Angelicae Sinensis, Herba Menthae, the Rhizoma Atractylodis Macrocephalae, Rhizoma Zingiberis Recens, add in the decoction pot, add 30 parts of water, soaked overnight, behind the heating extraction volatile oil C, decocting liquid filters, medicinal residues add 45 parts in water again, heated and boiled 1 hour, the filtrate extract merges filtrate twice, leave standstill cooling, filter, it is 1.1 extractum that the filtrate heating is condensed into proportion, stops heating, standing over night, get supernatant and advance spray dryer, 120 ℃ of inlet temperature controls, 113 ℃ of leaving air temps, 50,000 rev/mins of nebulizer rotating speeds, charging rate is 5ml/ minute, and spray-dired powder is crossed 100 mesh sieves, is Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, the prefabricated extract A of Rhizoma Zingiberis Recens;
(2) extract of the prefabricated Radix Paeoniae Alba, Poria, Radix Glycyrrhizae: get the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae by weight ratio, add in the Decocting pot, add 15 parts water, soaked overnight, heating decocted 2 hours, the filtrate extract, medicinal residues add 20 parts in water again, heated and boiled 1 hour, filtrate extract, merge filtrate twice, leave standstill cooling, filter, it is 1.0 extractum that the filtrate heating is condensed into proportion, drying promptly gets the prefabricated extract B of the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae;
(3) with the soybean isoflavone powder behind the crushing screening, prefabricated extract A, prefabricated extract B, vitamin E, microcrystalline Cellulose, low-substituted hydroxypropyl cellulose, pregelatinized Starch and vitamin C, divide another name fixed, put be mixed to the color and luster uniformity in the V-type blender after, put pelletize in the fluidized bed pelletizer, its control process parameters is as follows: 30 ℃ of air intakes, vibrate atomizing pressure 0.10bar, hydrojet speed 50g/ minute 2 times/minute, air door pressure 0.05mpa, auxiliary pneumatics 0.10mpa when treating that shaping particles is better, enters dry for the first time, inlet temperature is elevated to 60 ℃, vibrate air door pressure 0.1mpa, aux. pressure 0.10mpa 2 times/minute, the granule water content was controlled at 0.5% o'clock, took out granule;
(4) granule that makes sifts out the parts of fine granule by 16 mesh sieve granulate with 60 order dusting covers, adds the volatile oil C that extract (1), mixing the back thoroughly adds in the material, add micropowder silica gel again, abundant airtight spending the night behind the mixing, put 21 in the rotary tablet machine tabletting, sift out fine powder, remove useless sheets such as loose sheet, sliver, stain, sampling inspection changes in the coating pan after qualified, with hydroxypropyl emthylcellulose coating materials coating, obtain finished product.
Carry out conventional tablet detection with obtaining finished tablet, hardness can reach more than 4 kilograms, and the disintegration time of plain sheet is in 10 minutes.Conform to quality requirements.
Embodiment 2
The preparation of tablet of the present invention:
2 parts of soybean isoflavone, 3 parts of Radix Bupleuri, 3 parts of Radix Angelicae Sinensis, 0.5 part of Herba Menthae, 3 parts of the Rhizoma Atractylodis Macrocephalaes, 3 parts in Rhizoma Zingiberis Recens, 4 parts of the Radix Paeoniae Albas, 4 parts in Poria, 3 parts in Radix Glycyrrhizae, 1 part of vitamin C, 0.5 part of vitamin E, 5 parts of pregelatinized Starch, 5 parts of low-substituted hydroxypropyl celluloses, 5 parts of microcrystalline Cellulose, 0.5 part of micropowder silica gel, 1 part of hydroxypropyl emthylcellulose.
Preparation method: (1). prefabricated Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, the extract of Rhizoma Zingiberis Recens: by the Radix Bupleuri of described weight proportion, Radix Angelicae Sinensis, Herba Menthae, the Rhizoma Atractylodis Macrocephalae, Rhizoma Zingiberis Recens, add in the decoction pot, add 40 parts of water, soaked overnight, behind the heating extraction volatile oil C, decocting liquid filters, medicinal residues add 45 parts in water again, heated and boiled 1.5 hours, the filtrate extract merges filtrate twice, leave standstill cooling, filter, it is 1.2 extractum that the filtrate heating is condensed into proportion, stops heating, standing over night, get supernatant and advance spray dryer, 130 ℃ of inlet temperature controls, 120 ℃ of leaving air temps, 20,000 rev/mins of nebulizer rotating speeds, charging rate is 2ml/ minute, and spray-dired powder is crossed 100 mesh sieves, is Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, the prefabricated extract A of Rhizoma Zingiberis Recens:
(2) the prefabricated Radix Paeoniae Alba, Poria, the extract of Radix Glycyrrhizae: get the Radix Paeoniae Alba by weight ratio, Poria, Radix Glycyrrhizae adds in the Decocting pot, adds 20 parts water, soaked overnight, heating decocted 2 hours, and filtrate extract, medicinal residues add 23 parts in water again, heated and boiled 2 hours, the filtrate extract merges filtrate twice, leaves standstill cooling, filter, it is 1.2 extractum that filtrate heating is condensed into proportion, and standing over night is got supernatant and advanced spray dryer, 150 ℃ of inlet temperature controls, 95 ℃ of leaving air temps, 20,000 rev/mins of nebulizer rotating speeds, charging rate is 2ml/ minute, spray-dired powder is crossed 100 mesh sieves, is the Radix Paeoniae Alba, Poria, the prefabricated extract B of Radix Glycyrrhizae;
(3) with the soybean isoflavone powder behind the crushing screening, prefabricated extract A, prefabricated extract B, 0.5 part of vitamin E, 5 parts of microcrystalline Cellulose, 5 parts of low-substituted hydroxypropyl celluloses, 1 part of 5 parts of pregelatinized Starch and vitamin C, divide another name fixed, put be mixed to the color and luster uniformity in the V-type blender after, put pelletize in the fluidized bed pelletizer, its control process parameters is as follows: 40 ℃ of air intakes, vibrate atomizing pressure 0.2bar, hydrojet speed 60g/ minute 4 times/minute, air door pressure 0.1mpa, auxiliary pneumatics 0.15mpa when treating that shaping particles is better, enters dry for the first time, inlet temperature is elevated to 70 ℃, vibrate air door pressure 0.2mpa, aux. pressure 0.15mpa 4 times/minute, the granule water content was controlled at 1.5% o'clock, took out granule;
(4) the granule granulate that makes, sift out the parts of fine granule with 60 order dusting covers, add the volatile oil C that extract (1), mix the back thoroughly and add in the material, add 0.01 part of micropowder silica gel again, fully airtight spending the night behind the mixing, put 21 in the rotary tablet machine tabletting, sift out fine powder,, obtain finished product with hydroxypropyl emthylcellulose coating materials coating.
Embodiment 3
The preparation of tablet of the present invention:
6 parts of soybean isoflavone, 6 parts of Radix Bupleuri, 6 parts of Radix Angelicae Sinensis, 1.2 parts of Herba Menthaes, 6 parts of the Rhizoma Atractylodis Macrocephalaes, 6 parts in Rhizoma Zingiberis Recens, 6 parts of the Radix Paeoniae Albas, 6 parts in Poria, 4.8 parts in Radix Glycyrrhizae, 4 parts of vitamin Cs, 2 parts of vitamin Es, 2.5 parts of pregelatinized Starch, 2.5 parts of low-substituted hydroxypropyl celluloses, 2.5 parts of microcrystalline Cellulose, 0.1 part of micropowder silica gel, 5 parts of hydroxypropyl emthylcelluloses.
Preparation method: (1). prefabricated Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, the extract of Rhizoma Zingiberis Recens: by the Radix Bupleuri of described weight proportion, Radix Angelicae Sinensis, Herba Menthae, the Rhizoma Atractylodis Macrocephalae, Rhizoma Zingiberis Recens, add in the decoction pot, add 60 parts of water, soaked overnight, behind the heating extraction volatile oil C, decocting liquid filters, medicinal residues add 50 parts in water again, heated and boiled 2 hours, the filtrate extract merges filtrate twice, leave standstill cooling, filter, it is 1.3 extractum that the filtrate heating is condensed into proportion, stops heating, standing over night, get supernatant and advance spray dryer, 150 ℃ of inlet temperature controls, 125 ℃ of leaving air temps, 50,000 rev/mins of nebulizer rotating speeds, charging rate is 8ml/ minute, and spray-dired powder is crossed 100 mesh sieves, is Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, the prefabricated extract A of Rhizoma Zingiberis Recens;
(2) the prefabricated Radix Paeoniae Alba, Poria, the extract of Radix Glycyrrhizae: get 6 parts of the Radix Paeoniae Albas by weight ratio, 6 parts in Poria, 4.8 parts in Radix Glycyrrhizae adds in the Decocting pot, adds 30 parts water, soaked overnight, heating decocted 2 hours, and filtrate extract, medicinal residues add 25 parts in water again, heated and boiled 2.5 hours, the filtrate extract merges filtrate twice, leaves standstill cooling, filter, it is 1.3 extractum that filtrate heating is condensed into proportion, and standing over night is got supernatant and advanced spray dryer, 150 ℃ of inlet temperature controls, 125 ℃ of leaving air temps, 50,000 rev/mins of nebulizer rotating speeds, charging rate is 8ml/ minute, spray-dired powder is crossed 100 mesh sieves, is the Radix Paeoniae Alba, Poria, the prefabricated extract B of Radix Glycyrrhizae;
(3) with the soybean isoflavone powder behind the crushing screening, prefabricated extract A, prefabricated extract B, vitamin E2 part, 2.5 parts of microcrystalline Cellulose, 2.5 parts of low-substituted hydroxypropyl celluloses, 4 parts of 2.5 parts of pregelatinized Starch and vitamin Cs, divide another name fixed, put be mixed to the color and luster uniformity in the V-type blender after, put pelletize in the fluidized bed pelletizer, its control process parameters is as follows: 50 ℃ of air intakes, vibrate atomizing pressure 0.2bar, hydrojet speed 70g/ minute 6 times/minute, air door pressure 0.2mpa, auxiliary pneumatics 0.2mpa when treating that shaping particles is better, enters dry for the first time, inlet temperature is elevated to 90 ℃, vibrate air door pressure 0.3mpa, aux. pressure 0.2mpa 6 times/minute, the granule water content was controlled at 3.5% o'clock, took out granule;
(4) granule that makes is by 16 mesh sieve granulate, sift out the parts of fine granule with dusting cover, add the volatile oil C that extract (1), mix the back thoroughly and add in the material, add 0.1 part of micropowder silica gel again, fully airtight spending the night behind the mixing, put 21 in the rotary tablet machine tabletting, sift out fine powder,, obtain finished product with hydroxypropyl emthylcellulose coating materials coating.
Embodiment 4
The preparation of granule of the present invention:
2 parts of soybean isoflavone, 3 parts of Radix Bupleuri, 3 parts of Radix Angelicae Sinensis, 0.5 part of Herba Menthae, 3 parts of the Rhizoma Atractylodis Macrocephalaes, 3 parts in Rhizoma Zingiberis Recens, 4 parts of the Radix Paeoniae Albas, 4 parts in Poria, 3 parts in Radix Glycyrrhizae, 1 part of vitamin C, 0.5 part of vitamin E, 5 parts of cane sugar powders.
Preparation method:
(1) presses embodiment prefabricated extract A of 1 described method and extract B;
(2) with 2 parts in the soybean isoflavone powder behind the crushing screening; prefabricated extract A, prefabricated extract B, 0.5 part of vitamin E; 1 part of 5 parts of cane sugar powders and vitamin C; divide another name fixed, put be mixed to the color and luster uniformity in the V-type blender after, put pelletize in the fluidized bed pelletizer; its control process parameters is as follows: 40 ℃ of air intakes; vibrate atomizing pressure 0.10bar, hydrojet speed 60g/ minute 3-5 time/minute; air door pressure 0.1mpa; auxiliary pneumatics 0.10mpa when treating that shaping particles is better, enters dry for the first time; inlet temperature is elevated to 80 ℃; vibrate air door pressure 0.2mpa, aux. pressure 0.152mpa 3 times/minute; the granule water content was controlled at 1.5% o'clock; take out granule, behind the 16 mesh sieve granulate, remove fine powder with 60 mesh sieves sieve.
It is 4.8g/ people/sky that human body is recommended daily intaking amount.
By do the deferring senility experiment with quadrat method:
The result: 0.16%, 0.48%, 1.44% granule dosage group also can obviously prolong the average life of hero, female fruit bat, and male drosophila group and matched group comparing difference have significance, P<0.01, P<0.05, P<0.01, P<0.01; Female fruit bat group has significance than difference, P<0.01, P<0.01, P<0.01, P<0.05 compared with the control; 0.16%, 0.48%, 1.44% dosage group male drosophila half death time is respectively greater than matched group 2 days, 6 days, 7 days.0.16%, the female fruit bat half death time of 0.48%, 1.44% dosage group is respectively greater than matched group 1 day, 5 days, 5 days.
The result shows the compatibility science in the corresponding mixture ratio scope of soybean isoflavone and Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, Rhizoma Zingiberis Recens, the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae, and granule and Tabules all have the function of slow down aging.
But tablet carry take more convenient.
Embodiment 5
A kind of health food with slow down aging and beautification function, it mainly is to be made by the raw material of following weight portion: 2.5 parts of pregelatinized Starch, 2.5 parts of low-substituted hydroxypropyl celluloses, 2.5 parts of microcrystalline Cellulose, 0.1 part of micropowder silica gel, 0.2 part of hydroxypropyl emthylcellulose.All the other are with embodiment 1.
Embodiment 6
A kind of health food with slow down aging and beautification function, its excipient mainly is to be made by the raw material of following weight portion: 10 parts of pregelatinized Starch, 10 parts of low-substituted hydroxypropyl celluloses, 15 parts of microcrystalline Cellulose, 2.5 parts of micropowder silica gels, 2.5 parts of hydroxypropyl emthylcelluloses.All the other are with embodiment 2.
Embodiment 7
A kind of health food with slow down aging and beautification function, its excipient are 0.1 part of micropowder silica gels.All the other are with embodiment 2.
Embodiment 8
A kind of health food with slow down aging and beautification function, its excipient are 20 parts of cane sugar powders.All the other are with embodiment 4.
Embodiment 9
A kind of health food with slow down aging and beautification function, its excipient are 10 parts in mannitol.All the other are with embodiment 4.
Embodiment 10
A kind of health food with slow down aging and beautification function, its excipient are 2 parts in mannitol, cane sugar powder 10.All the other are with embodiment 4.
Embodiment 11
A kind of health food with slow down aging and beautification function, the total isoflavone content of soybean isoflavone is 10%.All the other are with embodiment 2.
Embodiment 12
A kind of health food with slow down aging and beautification function, the total isoflavone content of soybean isoflavone is 90%.All the other are with embodiment 2.
Embodiment 13
A kind of health food with slow down aging and beautification function, the total isoflavone content of soybean isoflavone is 30%.All the other are with embodiment 2.
Embodiment 14
A kind of health food with slow down aging and beautification function, the total isoflavone content of soybean isoflavone is 50%.All the other are with embodiment 2.
Embodiment 15
A kind of health food with slow down aging and beautification function, the total isoflavone content of soybean isoflavone is 40%.All the other are with embodiment 2.
A kind of health food with slow down aging and beautification function, form are capsule, routinely the prepared of capsule.All the other are with embodiment 2.
Embodiment 16
A kind of health food with slow down aging and beautification function, form are powder, routinely the prepared of powder.All the other are with embodiment 2.
Embodiment 17
The granule water content was controlled at 0.1% o'clock, took out granule; All the other are with embodiment 1.
Because of moisture content is too dried, the finished product that obtains is easy-formation not, and the sliver phenomenon is serious, can't 21 in the rotary tablet machine compression molding.
Embodiment 18
The granule water content was controlled at 4.0% o'clock, took out granule; All the other are with embodiment 1.
Because of moisture content is too damp, the finished product that obtains easily is clamminess, and behind the compression molding, the finished tablet that obtains is carried out conventional tablet detect, and hardness has only 2.5 kilograms.Tablet strength is not enough, and it is undesirable to chew mouthfeel.
Embodiment 19
A kind of tablet that contains soybean isoflavone, be the tablet of making by the following weight proportion raw material: 10 parts of soybean isoflavone, 2 parts of Radix Bupleuri, 2 parts of Radix Angelicae Sinensis, 0.4 part of Herba Menthae, 2 parts of the Rhizoma Atractylodis Macrocephalaes, 2 parts in Rhizoma Zingiberis Recens, 2 parts of the Radix Paeoniae Albas, 2 parts in Poria, 1.6 parts in Radix Glycyrrhizae, 0.6 part of vitamin C, 0.3 part of vitamin E, 10 parts of pregelatinized Starch, 10 parts of low-substituted hydroxypropyl celluloses, 2.5 parts of microcrystalline Cellulose, 0.1 part of micropowder silica gel, 0.2 part of hydroxypropyl emthylcellulose.All the other are with embodiment 2.
Do the deferring senility experiment in the same way:
Result: 0.08%, 0.24%, 0.72%; But the also average life of proper extension hero, female fruit bat of 0.48%, 1.44% tablet dose group 0.16%,, male drosophila group and matched group comparing difference have significance, P<0.05, P<0.01, P<0.01; Female fruit bat group has significance than difference, P<0.01, P<0.01, P<0.01 compared with the control; 0.08%, 0.24%, 0.72% dosage group male drosophila half death time is respectively greater than matched group 2 days, 3 days, 3 days.0.16%, the female fruit bat half death time of 0.48%, 1.44% dosage group is respectively greater than matched group 1 day, 3 days, 4 days.
The consumption that increases soybean isoflavone in the prescription reaches 10 parts, and the deferring senility experiment shows that super scope dosage uses the effect of soybean isoflavone poor slightly.
The too high deferring senility on the contrary of the consumption of soybean isoflavone effect is undesirable, and the consumption of soybean isoflavone too high being unfavorable for controls cost.Therefore under the fixed prerequisite of other composition consumptions, it is more reasonable that soybean isoflavone is controlled at 1-6 part.
Claims (7)
1, a kind of health food with slow down aging and beautification function, it is characterized in that it mainly is to be made by the raw material of following weight portion: soybean isoflavone 1-6 part, Radix Bupleuri 2-6 part, Radix Angelicae Sinensis 2-6 part, Radix Paeoniae Alba 2-6 part, Herba Menthae 0.4-1.2 part, Rhizoma Atractylodis Macrocephalae 2-6 part, Rhizoma Zingiberis Recens 2-6 part, Poria 2-6 part, Radix Glycyrrhizae 1.6-4.8 part, vitamin C 0.6-4 part, vitamin E 0.3-2 part, excipient 0.1-40 part.
2, the health food with slow down aging and beautification function according to claim 1 is characterized in that excipient 7.8-40 part.
3, the health food with slow down aging and beautification function according to claim 1, it is characterized in that excipient is made up of following materials of weight proportions single or multiple combination: pregelatinized Starch 2.5-10 part, low-substituted hydroxypropyl cellulose 2.5-10 part, microcrystalline Cellulose 2.5-15 part, micropowder silica gel 0.1-2.5 part, hydroxypropyl emthylcellulose 0.2-5 part, cane sugar powder 0-20 part, mannitol 0-10 part.
4, the health food with slow down aging and beautification function according to claim 1, the total isoflavone content that it is characterized in that soybean isoflavone is 10-90%.
5, the health food with slow down aging and beautification function according to claim 4, the total isoflavone content that it is characterized in that soybean isoflavone is 30-50%.
6, the health food with slow down aging and beautification function according to claim 1, the form that it is characterized in that described health food is tablet, capsule, granule and powder.
7, as having the preparation method of the health food of slow down aging and beautification function as described in the claim 3, the food preparation that it is characterized in that tablet form is by the poly-operation of following step:
(1) extract of prefabricated Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, Rhizoma Zingiberis Recens: get Radix Bupleuri by weight ratio, Radix Angelicae Sinensis, Herba Menthae, the Rhizoma Atractylodis Macrocephalae, Rhizoma Zingiberis Recens, add in the decoction pot, add 30-60 part water, soaked overnight, behind the heating extraction volatile oil C, decocting liquid filters, and medicinal residues add water 40-50 part again, heated and boiled 1-2 hour, the filtrate extract merges filtrate twice, leaves standstill cooling, filter, filtrate heating is condensed into the extractum that proportion is 1.0-1.3, and drying is the prefabricated extract A of Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, Herba Menthae, Rhizoma Zingiberis Recens;
(2) extract of the prefabricated Radix Paeoniae Alba, Poria, Radix Glycyrrhizae: get the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae by weight ratio, add in the Decocting pot, add the water of 15-30 part, soaked overnight, heating decocted 1-2.5 hour, the filtrate extract, medicinal residues add water 20-25 part again, heated and boiled 1 hour, filtrate extract, merge filtrate twice, leave standstill cooling, filter, the filtrate heating is condensed into the extractum that proportion is 1.0-1.3, drying promptly gets the prefabricated extract B of the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae;
(3) with the soybean isoflavone powder behind the crushing screening, prefabricated extract A, prefabricated extract B, vitamin E, microcrystalline Cellulose, low-substituted hydroxypropyl cellulose, pregelatinized Starch and vitamin C, divide another name fixed, put be mixed to the color and luster uniformity in the V-type blender after, put pelletize in the fluidized bed pelletizer, its control process parameters is as follows: air intake 30-50 ℃, vibrate atomizing pressure 0.10-0.2bar, hydrojet speed 50-70g/ minute 2-6 time/minute, air door pressure 0.05-0.2mpa, auxiliary pneumatics 0.10-0.2mpa when treating that shaping particles is better, enters dry for the first time, inlet temperature is elevated to 60-90 ℃, vibrate air door pressure 0.1-0.3mpa, aux. pressure 0.10-0.2mpa 2-6 time/minute, when the granule water content is controlled at 0.5-3.5%, take out granule;
(4) granule that makes sifts out the parts of fine granule by 16 mesh sieve granulate with 60 order dusting covers, adds the volatile oil C that extract (1), mixing the back thoroughly adds in the material, add micropowder silica gel again, abundant airtight spending the night behind the mixing, put 21 in the rotary tablet machine tabletting, sift out fine powder, remove useless sheets such as loose sheet, sliver, stain, sampling inspection changes in the coating pan after qualified, with hydroxypropyl emthylcellulose coating materials coating, obtain finished product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100026296A CN100534523C (en) | 2004-01-21 | 2004-01-21 | Health food having delaying senility and beautifying function and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100026296A CN100534523C (en) | 2004-01-21 | 2004-01-21 | Health food having delaying senility and beautifying function and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1647805A true CN1647805A (en) | 2005-08-03 |
CN100534523C CN100534523C (en) | 2009-09-02 |
Family
ID=34867410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100026296A Expired - Lifetime CN100534523C (en) | 2004-01-21 | 2004-01-21 | Health food having delaying senility and beautifying function and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100534523C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100443115C (en) * | 2006-04-27 | 2008-12-17 | 北京东方兴企食品工业技术有限公司 | Granule with beauty and health function |
CN101253977B (en) * | 2008-04-09 | 2012-05-30 | 黎秋萍 | Antioxidation anti-aging disease prevention biological food product |
CN103907929A (en) * | 2013-12-19 | 2014-07-09 | 黄培光 | Anti-aging health product capable of preventing and treating a plurality of diseases |
-
2004
- 2004-01-21 CN CNB2004100026296A patent/CN100534523C/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100443115C (en) * | 2006-04-27 | 2008-12-17 | 北京东方兴企食品工业技术有限公司 | Granule with beauty and health function |
CN101253977B (en) * | 2008-04-09 | 2012-05-30 | 黎秋萍 | Antioxidation anti-aging disease prevention biological food product |
CN103907929A (en) * | 2013-12-19 | 2014-07-09 | 黄培光 | Anti-aging health product capable of preventing and treating a plurality of diseases |
Also Published As
Publication number | Publication date |
---|---|
CN100534523C (en) | 2009-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1857642A (en) | Quality control method for depression relieving and tranquilizing preparation | |
CN1233387C (en) | Chinese compound medicine for treating anhypnosis and its preparation metod | |
CN1814216A (en) | Chinese medicine composition for diminishing speckle and pox | |
CN1239183C (en) | A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof | |
CN1698878A (en) | Kidney replenishing medicinal composition and its preparation process and novel use | |
CN1917895A (en) | Extracts of houttuynia cordata and rubus coreanus and their composition for preventing and treating allergic diseases | |
CN1559495A (en) | Deer's fetus granular Chinese madicinal preparation and its production technology | |
CN1256124C (en) | Blood-supplementing medicine composition | |
CN1647805A (en) | Health food having delaying senility and beautifying function and its preparing method | |
CN101036722A (en) | Health-caring food for easing and improving climacteric Syndrome of men and the preparation thereof | |
CN1548138A (en) | Chinese medicine composition for treating consumptive disease and its quality control method | |
CN1335161A (en) | Deer bone powder capsule | |
CN1276775C (en) | Chinese traditional medicine for treating optical fundus hemorrhage and its preparing process | |
CN1254266C (en) | Capsule for treating coryza and its preparation method | |
CN1268377C (en) | Preparation for improving bioavailability and medicine effect for treating gynecopathy and preparing method | |
CN1679658A (en) | Chinese medicine preparation for treating AIDS and process thereof | |
CN1102061C (en) | Enqlish yew-manna tea | |
CN1323700C (en) | Traditional Chinese medicine composition for treating deficiency disease and preparation method and quality standard thereof | |
CN1533805A (en) | Capsule formula for treating astriction prepared using pumpkin as main raw material and its preparation method | |
CN1927161A (en) | Shower milk-like liquid and its preparation method | |
CN1602945A (en) | Rhinitis treating soft medicinal capsule and preparation process thereof | |
CN1235841C (en) | Method for preparing extract of peanut leaf | |
CN1069537C (en) | Medicine for weight-reducing and beautifying | |
CN1651017A (en) | Medicinal composition for treating cervical vertebra disease and its preparation method | |
CN1256978C (en) | Medicine for tonifying kidney, promoting generation of vital essence and reinforcing primordial qi, and strengthening and its preparing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20090902 |